Effects of GnRH Agonist and Dienogest in Combination on HE4 and CA125 Levels in Patients with Adenomyosis and Adenomyoma: A Prospective Cohort Study
Background: The traditional pathology of adenomyosis (AM) suggests that this is a common benign uterine disease. Hysterectomy is the gold standard of care and is viewed as a decisive treatment for AM; however, more conservative treatment approaches are required to maintain fertility. Unfortunately,...
Saved in:
| Main Authors: | DongGe Wang, LiMei Ji, CenLin Jia, MingJun Shao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2023-07-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/50/7/10.31083/j.ceog5007156 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series
by: Haruka Nishida, et al.
Published: (2025-03-01) -
Secondary cystic adenomyosis in a young woman: a case report
by: Hong-Xuan Li, et al.
Published: (2022-09-01) -
A Rare Case of Multiple Subserous Uterine Adenomyomas Misdiagnosed as an Ovarian Cyst, Diagnosed and Treated by Laparoscopy
by: Fei H, et al.
Published: (2024-12-01) -
Long-term clinical outcomes of dienogest for perimenopausal women with symptomatic adenomyosis
by: Chi-Hau Chen, et al.
Published: (2025-03-01) -
The impact of GnRH agonists on endometrial immune cells in patients with adenomyosis: a prospective cohort study
by: Anna Lena Zippl, et al.
Published: (2025-06-01)